Hawkins Inc. Common Stock (HWKN)

FairStock Score: 37/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach Hawkins as a small specialty chemicals and water-treatment business with a $2.8 billion market value, 1,200 employees, and a cyclical label from FairStock. The filed record shows revenue growth but uneven earnings. In fiscal Q1 2026, the quarter ended 2026-06-28, revenue was $315.7 million, net income $28.3 million, and diluted EPS $1.35. A year earlier, in fiscal Q1 2025 ended 2025-06-29, revenue was $293.3 million, net income $29.2 million, and diluted EPS $1.40. So sales rose while profit and EPS slipped. For fiscal year 2025 ended 2026-03-29, revenue was $1.1 billion, net income $81.5 million, and diluted EPS $3.91; that compares with fiscal year 2024 ended 2025-03-30 revenue of $974.4 million, net income of $84.3 million, and diluted EPS of $4.03. The long-term revenue trend is up, but earnings have not compounded smoothly. I cannot identify a wide moat from these numbers; water-treatment demand can be recurring, but specialty chemicals is competitive and cyclical. The balance sheet looks sound: FairStock's Piotroski F-Score is 9/9, Altman Z-Score 4.94, D/E 0.47, and ROE 15.61%. Yet ROCE is only 7.05%, which suggests modest returns on total capital. Price is the rub. At $131.89 on 2026-10-13, FairStock calculates P/E 34.17, P/B 6.24, EV/EBITDA 17.19, FCF yield 3.3%, and a Graham Number of $47.91. The margin of safety is -175.29%, and the FairStock Score is 37/100. I see a decent, cyclical operator, but not a bargain; the quote already assumes a much stronger earnings trajectory than recent filings show.

In plain English: Hawkins makes chemicals and ingredients used for treating water and for food, health, and industrial customers. The company is profitable and its balance sheet looks solid, but recent profit slipped even as sales grew. At the recent price, the stock looks expensive compared with its profits and accounting value.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q1 2026 10-Q (period ended 2026-06-28) · fiscal Q3 2025 10-Q (period ended 2025-12-28) · fiscal Q2 2025 10-Q (period ended 2025-09-28) · fiscal Q1 2025 10-Q (period ended 2025-06-29) · FY2025 10-K (period ended 2026-03-29) · FY2024 10-K (period ended 2025-03-30) · FY2023 10-K (period ended 2024-03-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer